Hydrochloric Acid → 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-5-oxo-pentanoic acid methyl ester

HRID 858909

반응식

HRID 858909 반응식
[CH3:1][O:2][C:3](=[O:29])[CH:4]([C:12]1[N:16]2[CH:17]=[C:18]([CH3:21])[CH:19]=[CH:20][C:15]2=[N:14][C:13]=1[C:22]1[CH:27]=[CH:26][C:25]([CH3:28])=[CH:24][CH:23]=1)[CH2:5][CH2:6][CH:7]1OCC[O:8]1.Cl>CC(C)=O>[CH3:1][O:2][C:3](=[O:29])[CH:4]([C:12]1[N:16]2[CH:17]=[C:18]([CH3:21])[CH:19]=[CH:20][C:15]2=[N:14][C:13]=1[C:22]1[CH:27]=[CH:26][C:25]([CH3:28])=[CH:24][CH:23]=1)[CH2:5][CH2:6][CH:7]=[O:8]

참가 물질

4

실험 절차

To a magnetically stirred solution of (+/−)-4-[1,3]dioxolan-2-yl-2-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-butyric acid methyl ester 35b (0.10 g, 0.253 mmol) in acetone (5 mL) at room temperature under Ar atmosphere was slowly added 5N HCl (1.5 mL). The reaction mixture was stirred for 2 h and then concentrated in vacuo to remove acetone. NaHCO3 solution (100 mL) was added until the pH is greater than 9, and the aqueous phase was extracted with ethyl acetate (2×100 mL). The combined organic layers were washed with water, dried (MgSO4), and concentrated in vacuo to provide 0.064 g (75%) of the crude product. 1H NMR (400 MHz, CDCl3) δ 2.24 (m, 4H), 2.34 (s, 3H), 2.39 (s, 3H), 3.70 (s, 3H), 4.38 (t, J=8.1 Hz, 1H), 7.03 (d, J=1.4 Hz, 1H), 7.24 (d, J=7.3 Hz, 2H), 7.56 (m, 3H), 7.99 (s, 1H), 9.48 (s, 1H).

후처리

  1. customat room temperature
  2. concentrationconcentrated in vacuo
  3. customto remove acetone
  4. additionNaHCO3 solution (100 mL) was added until the pH is greater than 9
  5. extractionthe aqueous phase was extracted with ethyl acetate (2×100 mL)
  6. washThe combined organic layers were washed with water
  7. dry with materialdried (MgSO4)
  8. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-87bc952b95994704a40d551c6da0eab6
출처 데이터셋
uspto-grants-2006_12
특허 번호
US07148353B2

연결된 노트

불러오는 중…